Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05324501
Title A Study of Intra-tumoral Administered MTX110 in Patients With Recurrent Glioblastoma (MAGIC-G1)
Acronym MAGIC-G1
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Midatech Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.